The current valuation score of TriSalus Life Sciences Inc is 6.25, ranking 318 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.20, which is -100.00% below the recent high of 0.00 and -70.20% above the recent low of -5.44.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.